Bioshares Biotechnology Clinical Trials Fund (BBC)

Description:

Etfis Series Trust I - Bioshares Biotechnology Clinical Trials Fund is an exchange traded fund launched and managed by Etfis Capital LLC. The fund is co-managed by LifeSci Index Partners, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in the stocks of companies operating in the biotechnology sector. It invests in the stocks of biotechnology companies which have a primary product offering that is in a Phase 1, Phase 2 or Phase 3 of clinical trial stage of development. The fund invests in stocks of companies across all market capitalizations with market capitalization of $250 million or more. It seeks to replicate the performance of the BioShares Biotechnology Clinical Trials Index, by investing in the stocks of companies as per their weightings in the index. The fund does not invest in companies operating in sectors such as medical devices and diagnostics; life science tools; specialty pharmaceuticals, generic drugs and outsourced drug delivery; healthcare services; contract research organizations; neutraceuticals; agricultural biotechnology; animal health; diversified healthcare; food sciences; information technology; nanotechnology; and companies which focus mainly on acquiring biotechnology companies. Etfis Series Trust I - Bioshares Biotechnology Clinical Trials Fund was formed on December 16, 2014 and is domiciled in the United States. [read more]

Last Trade: $24.50
Trade Time: 06/23/2017
Prev Close: $24.50
Open: $24.69
High: $25.10
Low: $24.09
Volume: 21,201
Optionable: No
Yield: 0
Annual Dividend: 0
Dividend Freq:
Leverage: No
Inverse: No
Expense Ratio: 0.850
Inception Date: 12/16/2014
  • Healthcare (0.0000%)

  • United States (0.0000%)
  • Bermuda (0.0000%)
  • Canada (0.0000%)
  • (0.0000%)